‌

US Patent 9504762 Adeno-associated virus factor VIII vectors

Patent 9504762 was granted and assigned to Biomarin Pharmaceutical on November, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Biomarin Pharmaceutical

0

Current Assignee

Biomarin Pharmaceutical

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jenny Mcintosh0

Amit Nathwani0

Edward Tuddenham0

Peter Cameron Colosi0

Date of Patent

November 29, 2016

0

Patent Application Number

144826480

Date Filed

September 10, 2014

0

Patent Citations Received

US Patent 11707536 Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A

0

US Patent 12091675 Gene therapy of hemophilia a using viral vectors encoding recombinant FVIII variants with increased expression

0

US Patent 11975056 AADC polynucleotides for the treatment of Parkinson's disease

0

US Patent 11759506 AADC polynucleotides for the treatment of Parkinson's disease

Patent Primary Examiner

0

Patent abstract

The invention provides improved adeno-associated virus (AAV) Factor VIII (FVIII) vectors, including AAV FVIII vectors that produce a functional Factor VIII polypeptide and AAV FVIII vectors with high expression activity.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9504762 Adeno-associated virus factor VIII vectors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.